Pimavanserin Clinical Trials
5 recruitingDrug
Phase 43Phase 22
Showing 1–5 of 5 trials
Recruiting
Phase 2
Psilocybin Therapy for Depression in Parkinson's Disease
DepressionParkinson Disease
Joshua Woolley, MD, PhD60 enrolled1 locationNCT06455293
Recruiting
Phase 4
Comparing Antipsychotic Medications in LBD Over Time
Dementia With Lewy BodiesParkinson's Disease Psychosis
The University of Texas Health Science Center at San Antonio94 enrolled2 locationsNCT05590637
Recruiting
Phase 4
Pimavanserin vs. Quetiapine for Treatment of Parkinson's Psychosis
Parkinson's Disease Psychosis
VA Office of Research and Development358 enrolled24 locationsNCT04373317
Recruiting
Phase 4
Characterization of the Serotonin 2A Receptor Selective PET Tracer [18F]MH.MZ in Patients With Neurodegenerative Diseases
Parkinson DiseaseNeurodegenerative DiseasesParkinson Disease Psychosis
Vanderbilt University Medical Center75 enrolled1 locationNCT05357612
Recruiting
Phase 2
Psilocybin With Pimavanserin Compared to Psilocybin Alone for the Treatment of Major Depressive Disorder
Major Depressive Disorder
Icahn School of Medicine at Mount Sinai60 enrolled1 locationNCT06592833